A detailed history of Boston Partners transactions in Pfizer Inc stock. As of the latest transaction made, Boston Partners holds 3,156,897 shares of PFE stock, worth $88.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,156,897
Previous 3,156,897 -0.0%
Holding current value
$88.3 Million
Previous $87.6 Million -0.0%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $1.82 Million - $2.09 Million
-70,171 Reduced 2.17%
3,156,897 $87.6 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $6.95 Million - $9.02 Million
-265,885 Reduced 7.61%
3,227,068 $92.9 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $4.26 Million - $4.99 Million
-132,898 Reduced 3.67%
3,492,953 $116 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $10.7 Million - $12.4 Million
-295,963 Reduced 7.55%
3,625,851 $133 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $2.66 Million - $3.46 Million
-67,448 Reduced 1.69%
3,921,814 $160 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $10.8 Million - $14.1 Million
-259,215 Reduced 6.1%
3,989,262 $204 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $11.1 Million - $13.6 Million
-254,552 Reduced 5.65%
4,248,477 $186 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $8.37 Million - $9.93 Million
-179,956 Reduced 3.84%
4,503,029 $236 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $7.89 Million - $9.78 Million
-172,459 Reduced 3.55%
4,682,985 $243 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $361 Million - $535 Million
-8,738,563 Reduced 64.28%
4,855,444 $287 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $8.24 Million - $10.6 Million
209,908 Added 1.57%
13,594,007 $585 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $1.41 Million - $1.59 Million
-39,170 Reduced 0.29%
13,384,099 $524 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $38.7 Million - $43.7 Million
-1,156,449 Reduced 7.93%
13,423,269 $487 Million
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $199 Million - $254 Million
-5,958,971 Reduced 29.01%
14,579,718 $537 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $38.5 Million - $45.2 Million
-1,213,560 Reduced 5.58%
20,538,689 $754 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $92.9 Million - $113 Million
-3,085,529 Reduced 12.42%
21,752,249 $712 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $57.3 Million - $81.9 Million
2,119,534 Added 9.33%
24,837,778 $811 Million
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $9.88 Million - $11.2 Million
300,226 Added 1.34%
22,718,244 $890 Million
Q3 2019

Nov 20, 2019

SELL
$32.49 - $42.13 $43.6 Million - $56.5 Million
-1,341,954 Reduced 5.65%
22,418,018 $806 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $115,891 - $150,277
3,567 Added 0.02%
23,759,972 $1.03 Billion
Q2 2019

Aug 26, 2019

SELL
$36.98 - $41.52 $49,183 - $55,221
-1,330 Reduced 0.01%
23,756,405 $1.03 Billion
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $34.9 Million - $39.2 Million
-943,203 Reduced 3.82%
23,757,735 $1.03 Billion
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $136 Million - $149 Million
-3,620,159 Reduced 12.78%
24,700,938 $1.05 Billion
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $8.06 Million - $9.19 Million
-209,534 Reduced 0.73%
28,321,097 $1.24 Billion
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $19.1 Million - $23.2 Million
-554,691 Reduced 1.91%
28,530,631 $1.26 Billion
Q2 2018

Aug 03, 2018

SELL
$32.98 - $35.16 $3.55 Million - $3.79 Million
-107,782 Reduced 0.37%
29,085,322 $1.06 Billion
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $12.8 Million - $14.8 Million
400,862 Added 1.39%
29,193,104 $1.04 Billion
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $35 Million - $37.1 Million
1,050,922 Added 3.79%
28,792,242 $1.04 Billion
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $860 Million - $947 Million
27,741,320
27,741,320 $990 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.